TheraVet Strengthens Its Sales Organisation in France by Signing an Important Distribution Agreement for BIOCERA-VET®
GOSSELIES, Belgium–(BUSINESS WIRE)–Regulatory News: TheraVet (Paris:ALVET) (Brussels:ALVET) (ISIN: BE0974387194 – ticker: ALVET), a biotech company developing pioneering treatments for osteoarticular disease in pets, announced today...

